Why measure C reactive protein?
作者信息
Mazlam M Z, Hodgson H J
机构信息
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
出版信息
Gut. 1994 Jan;35(1):5-7. doi: 10.1136/gut.35.1.5.
Abstract
摘要
相似文献
1
Why measure C reactive protein?为什么要检测C反应蛋白？
Gut. 1994 Jan;35(1):5-7. doi: 10.1136/gut.35.1.5.
2
C-Reactive Protein Levels Together with the Ranson Scoring System to Differentiate the Mild and Severe Forms of Acute Pancreatitis.
Turk J Gastroenterol. 2017 May;28(3):157-158. doi: 10.5152/tjg.2017.25041.
3
Serum Procalcitonin Is a Candidate Biomarker to Differentiate Bacteremia from Disease Flares in Patients with Inflammatory Bowel Disease.血清降钙素原是区分炎症性肠病患者菌血症与疾病发作的候选生物标志物。
Gut Liver. 2016 Jul 15;10(4):491-2. doi: 10.5009/gnl16272.
4
Would measurement of C-reactive protein reduce the rate of negative exploration for acute appendicitis?检测C反应蛋白会降低急性阑尾炎阴性探查率吗？
J R Coll Surg Edinb. 2000 Jun;45(3):202; author reply 203.
5
[Procalcitonin as a marker of intra-abdominal infection].[降钙素原作为腹腔内感染的标志物]
Cir Cir. 2014 Mar-Apr;82(2):231-9.
6
Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity?英夫利昔单抗治疗后循环骨保护素（OPG）水平降低，且与CRP水平相关：血清OPG是否为炎症性肠病（IBD）疾病活动的潜在标志物？
Inflamm Bowel Dis. 2011 Jun;17(6):E59-60. doi: 10.1002/ibd.21714. Epub 2011 Mar 23.
7
C-reactive protein and acute pancreatitis.C反应蛋白与急性胰腺炎
Br J Surg. 1989 Aug;76(8):877. doi: 10.1002/bjs.1800760837.
8
C-reactive protein and acute appendicitis.C反应蛋白与急性阑尾炎
J R Coll Surg Edinb. 1988 Jun;33(3):115-6.
9
Hyperlipasemia in Pediatric Inflammatory Bowel Diseases.儿童炎症性肠病中的高脂血症
Pancreas. 2016 Feb;45(2):e2-3. doi: 10.1097/MPA.0000000000000513.
10
Predictive value of C-reactive protein/albumin ratio in acute pancreatitis.C 反应蛋白/白蛋白比值在急性胰腺炎中的预测价值。
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):424-430. doi: 10.1016/S1499-3872(17)60007-9.
引用本文的文献
1
Comparison of Fecal Calprotectin with Different Endoscopic Scores in the Assessment of Ulcerative Colitis (UC) Activity and Its Utility in Differentiating IBS from IBD.粪便钙卫蛋白与不同内镜评分在溃疡性结肠炎（UC）活动度评估中的比较及其在鉴别肠易激综合征（IBS）和炎症性肠病（IBD）中的应用
Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):120-123. doi: 10.5005/jp-journals-10018-1411.
2
Anti-Ulcerative Effect of Curcumin-Galactomannoside Complex on Acetic Acid-Induced Experimental Model by Inhibiting Inflammation and Oxidative Stress.姜黄素-半乳甘露聚糖复合物通过抑制炎症和氧化应激对乙酸诱导的实验模型的抗溃疡作用。
Inflammation. 2020 Aug;43(4):1411-1422. doi: 10.1007/s10753-020-01218-9.
3
C-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn's disease.围手术期C反应蛋白水平作为克罗恩病回结肠切除术后内镜复发的预测标志物
Cell Death Discov. 2016 May 23;2:16032. doi: 10.1038/cddiscovery.2016.32. eCollection 2016.
4
Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer.炎症与免疫功能生物标志物及结直肠癌风险
Curr Colorectal Cancer Rep. 2015;11(5):250-258. doi: 10.1007/s11888-015-0282-5.
5
Laboratory markers in ulcerative colitis: Current insights and future advances.溃疡性结肠炎的实验室标志物：当前见解与未来进展
World J Gastrointest Pathophysiol. 2015 Feb 15;6(1):13-22. doi: 10.4291/wjgp.v6.i1.13.
6
Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.使用定量免疫化学粪便隐血试验预测溃疡性结肠炎的发作。
World J Gastroenterol. 2010 Mar 7;16(9):1110-4. doi: 10.3748/wjg.v16.i9.1110.
7
Soluble adhesion molecules in inflammatory bowel disease.炎症性肠病中的可溶性黏附分子
Ir J Med Sci. 2001 Apr-Jun;170(2):107-11. doi: 10.1007/BF03168821.
8
A simple method for assessing intestinal inflammation in Crohn's disease.一种评估克罗恩病肠道炎症的简单方法。
Gut. 2000 Oct;47(4):506-13. doi: 10.1136/gut.47.4.506.
9
Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target?17-1A抗原在胃及胃食管交界腺癌中的表达：一个潜在的免疫治疗靶点？
J Clin Pathol. 1999 Sep;52(9):701-4. doi: 10.1136/jcp.52.9.701.
10
本文引用的文献
1
C-reactive protein and the acute-phase response.C反应蛋白与急性期反应
J Lab Clin Med. 1981 Jun;97(6):739-49.
2
Assessment of drug therapy in inflammatory bowel disease.炎症性肠病的药物治疗评估
Br J Clin Pharmacol. 1982 Aug;14(2):159-70. doi: 10.1111/j.1365-2125.1982.tb01957.x.
3
The phenomenon of the acute phase response.急性期反应现象
Ann N Y Acad Sci. 1982;389:39-48. doi: 10.1111/j.1749-6632.1982.tb22124.x.
4
C-reactive protein and the acute phase response.C反应蛋白与急性期反应
Adv Intern Med. 1982;27:345-72.
5
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎患者血清C反应蛋白水平
Eur J Clin Invest. 1982 Aug;12(4):351-9. doi: 10.1111/j.1365-2362.1982.tb02244.x.
6
Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein.C反应蛋白与染色质及核小体核心颗粒的结合。C反应蛋白的一种可能生理作用。
J Biol Chem. 1984 Jun 10;259(11):7311-6.
7
Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.急性期蛋白，特别涉及C反应蛋白及相关蛋白（五聚素）和血清淀粉样蛋白A。
Adv Immunol. 1983;34:141-212. doi: 10.1016/s0065-2776(08)60379-x.
8
Interleukin-1 and the pathogenesis of the acute-phase response.白细胞介素-1与急性期反应的发病机制。
N Engl J Med. 1984 Nov 29;311(22):1413-8. doi: 10.1056/NEJM198411293112205.
9
C-reactive protein fifty years on.五十年后的C反应蛋白。
Lancet. 1981 Mar 21;1(8221):653-7. doi: 10.1016/s0140-6736(81)91565-8.
10
The liver as the site of C-reactive protein formation.肝脏作为C反应蛋白的形成部位。
J Exp Med. 1966 Feb 1;123(2):365-78. doi: 10.1084/jem.123.2.365.
Zotero 插件